Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SERPINB1 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5145401
Description
For immunocytochemistry the cells were formalin fixed.
Regulates the activity of the neutrophil proteases elastase, cathepsin G, proteinase-3, chymase, chymotrypsin, and kallikrein-3.
Specifications
SERPINB1 | |
Polyclonal | |
Unconjugated | |
Serpinb1a | |
1190005M04Rik; AI325983; Anti elastase; anti-elastase; EGK_14416; EI; EIA; ELANH2; epididymis luminal protein 57; epididymis secretory protein Li 27; HEL57; HEL-S-27; L M/N MN PI2; LEI; leukocyte elastase inhibitor; Leukocyte elastase inhibitor A; M/NEI; MNEI; Monocyte/neutrophil elastase inhibitor; ovalbumin; peptidase inhibitor 2; PI2; PI-2; protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived; serine (or cysteine) peptidase inhibitor, clade B, member 1a; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1a; serine (or cysteine) proteinase inhibitor, clade B, member 1a; serine protease inhibitor EIA; serpin; Serpin B1; Serpin B1a; serpin family B member 1; serpin peptidase inhibitor, clade B (ovalbumin), member 1; Serpinb1; Serpinb1a | |
Rabbit | |
Protein A | |
RUO | |
291091, 66222 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
ELISA, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.5 mg/mL | |
PBS with 50% glycerol and 0.05% Proclin 300; pH 7.4 | |
Q4G075, Q9D154 | |
Serpinb1a | |
Recombinant Rat LEI protein, His17-Glu332 (Accession #Q4G075). | |
200 μL | |
Primary | |
Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction